ArticleBrachytherapy
Automated daily check QA of treatment channel adjustments (TCA), active, and dummy source positioning using bravos after loader.
Article in Brachytherapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeAs HDR afterloader technology evolves, new treatment delivery capabilities create opportunities to reinforce quality assurance (QA) procedures. We present a novel method of automated log file analysis for daily, longitudinal tracking of channel length offsets, and active and dummy source positional accuracy. Leveraging features of the Bravos afterloader system, the method supplements visual inspections and functional tests, enhancing QA accuracy and reliability. METHODS/MATERIALS: Our clinic utilizes 3 HDR afterloaders across 4 vaults, delivering over 900 treatments annually. Applicators and transfer guide tubes (TGTs) vary in length and connectors. We collected treatment reports and daily Position Verification Test (PVT) logs over 9 months resulting in 694 and 455 treatment reports and PVT logs, respectively. Each TGT is assigned a unique identifier (UID) to monitor readings over time, including dedicated TGTs used in PVT readings. Statistical analysis was performed per afterloader across 3 CamScales, and later grouped by CamScale to assess deviations from expected distances and identify trends in TGT and PVT measurements.
resultsPVT readings for dummy (and active) sources are within 0.05 cm, for 97% (91%), 90% (97%), and 97% (94%) of readings for Afterloaders A1, A2, and A3, respectively, across all CamScales. Postcalibration distances compared to the precalibration distances result in an average difference of <0.03 cm for active and dummy sources. Across 7421 treatment channels adjustments (TCAs), 74 exceeded the overall threshold of 2 mm, decreasing to 7 when group-specific thresholds were applied.
conclusionThe implementation of an automated QA program of treatment channel adjustments in HDR brachytherapy has benefits in maintaining the accuracy and reliability of TGT measurements and applicators. Daily QA checks provide a comprehensive overview of trends, enabling early detection of potential issues and timely interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.